Tocqueville Asset Management’s Cidara Therapeutics CDTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,150
| Closed | -$150K | – | 530 |
|
|
2024
Q1 | $150K | Buy |
8,150
+3,400
| +72% | +$62.6K | ﹤0.01% | 518 |
|
|
2023
Q4 | $75.4K | Sell |
4,750
-150
| -3% | -$2.38K | ﹤0.01% | 509 |
|
|
2023
Q3 | $92.3K | Sell |
4,900
-750
| -13% | -$14.1K | ﹤0.01% | 497 |
|
|
2023
Q2 | $128K | Sell |
5,650
-2,700
| -32% | -$61K | ﹤0.01% | 520 |
|
|
2023
Q1 | $212K | Buy |
8,350
+1,550
| +23% | +$39.4K | ﹤0.01% | 493 |
|
|
2022
Q4 | $103K | Buy |
6,800
+1,600
| +31% | +$24.2K | ﹤0.01% | 562 |
|
|
2022
Q3 | $65K | Buy |
+5,200
| New | +$65K | ﹤0.01% | 587 |
|